Therapy Areas: Diabetes
Arch Biopartners engages private lab to advance IL-32 chronic kidney disease programme
20 July 2026 - Canada-based biotechnology company Arch Biopartners Inc (TSX-V:ARCH) (OTCQB:ACHFF) announced on Friday that it has engaged a US-based laboratory specialising in bioengineering to accele...
Lakewood-Amedex Biotherapeutics reports positive Nu-3 Gel preclinical safety data for upcoming Phase 2a trial
16 July 2026 - Clinical-stage biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT) on Wednesday announced preclinical safety data for its Nu-3 gel formulation that establishes a str...
Insulet expands European footprint with Omnipod 5 and Omnipod Discover launch in Spain
6 July 2026 - Medical device company Insulet Corporation (NASDAQ:PODD) announced on Monday the launch of its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data platform in Spain, ma...
LyGenesis granted funding for research project to induce immune tolerance to pancreatic islet transplantation
26 June 2026 - LyGenesis, Inc., a US-based, clinical-stage biotechnology company developing cell therapies for organ regeneration, announced on Thursday that it has received a research award from Brea...
Cirius Therapeutics commences enrolment and dosing for Phase 2 study of CIR-0602K in type 1 diabetes
25 June 2026 - Cirius Therapeutics Inc, a developer of innovative therapies for people suffering from diseases caused by mitochondrial dysfunction and insulin resistance, announced on Wednesday that e...
Novo Nordisk Foundation funds European initiative to accelerate drug discovery for cardiometabolic diseases
22 June 2026 - The Novo Nordisk Foundation, a philanthropic enterprise foundation created by Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO), announced on Friday that it is fund...